Home Cart 0 Sign in  

[ CAS No. 127423-61-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 127423-61-4
Chemical Structure| 127423-61-4
Structure of 127423-61-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 127423-61-4 ]

Related Doc. of [ 127423-61-4 ]

Alternatived Products of [ 127423-61-4 ]

Product Details of [ 127423-61-4 ]

CAS No. :127423-61-4 MDL No. :MFCD06809586
Formula : C10H19NO5S Boiling Point : -
Linear Structure Formula :- InChI Key :KWQRKOSMSFLBTJ-MRVPVSSYSA-N
M.W : 265.33 Pubchem ID :10934372
Synonyms :

Safety of [ 127423-61-4 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P301+P310 UN#:2811
Hazard Statements:H301 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 127423-61-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 127423-61-4 ]
  • Downstream synthetic route of [ 127423-61-4 ]

[ 127423-61-4 ] Synthesis Path-Upstream   1~14

  • 1
  • [ 83220-73-9 ]
  • [ 124-63-0 ]
  • [ 127423-61-4 ]
YieldReaction ConditionsOperation in experiment
100% With triethylamine In dichloromethane at 20℃; Cooling with ice Example 20. N-(4-(4-amino-l-((S)-pyrrolidin-3-yl)-lH-pyrazolo[3,4-d]pyrimidin-3- yl)phenyl)-3-(trifluoromethyl)benzamide (AD070); Step 1; [0200] (i?)-l-(ter.pound.-butoxycarbonyl)pyrrolidin-3-yl methanesulfonate. A solution of (R)- tert-bntyl 3-hydroxypyrrolidine-l-carboxylate (1.0 g, 5.3 mmol) and triethylamine (2.77 mL, 20 mmol) in CH2Cl2 (20 mL) was cooled in an ice-water bath. To this, methanesulfonyl chloride (1.15 mL, 15 mmol) diluted in CH2Cl2 (10 mL) was added dropwise. The reaction was left stirring for 12 hours at room temperature. Water was added, and organic phases extracted in CH2Cl2 (3x 50 mL), which were subsequently dried onto silica and purified by silica gel chromatography (50percent EtOAc:Hexanes to 100percent EtOAc gradient) to afford (R)-I- (te/t-butoxycarbonyl)pyrrolidin-3-yl methanesulfonate (1.53 g, brown oil, 100percent yield).
100% With triethylamine In dichloromethane at 0 - 20℃; for 2 h; (R)-tert-butyl 3-hydroxypyrrolidine-l-carboxylate (5.0 g, 26.7 mmol) and Et3N (8.0 g, 80.2 mmol) were dissolved in dichloromethane (50 mL). The mixture was stirred at 0°C for 30 minutes, then methanesulfonyl chloride (4.5 g, 40.1 mmol) was added dropwise. It was stirred at room temperature for 2 h and concentrated under reduced pressure. DCM (50 mL) and water (50 mL) were added. The organic phase was washed with saturated NaHC03 (30 mL) and H20 (2 x 30 mL), and concentrated to afford the title compound as oil (6 g, 100percent).
100% With triethylamine In dichloromethane at 0 - 20℃; for 1 h; Inert atmosphere To a solution of (R)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate (1.00 g, 5.35 mmol) and TEA (1.62 mg, 16.1 mmol) in DCM (15 mL)was added MsCI (0.920 g, 8.03 mmol) at 0°Cunder N2. The mixture was warmed to room temperature and stirred for another 1 h. The mixture was diluted with H20 (40 mL) and extracted with EtOAc (3 x 20 mL). The combined organic layers were washed with sat.NaHCO3 aq. brine, dried over Na2SO4 and concentrated in vacuum to give the desired product (1.4 g, yield 100percent) as yellow oil.1H NMR (300 MHz, CDCI3): 65.29-5.24 (m, 1H), 3.72-3.43 (m, 4H), 305 (s, 3H), 2.35-2.08(m, 2H), 1.47 (s, 9H).LC-MS: [mobile phase: from 90percent water (0.02percent NH4OAc) and 10percent CH3CN to 5percent water (0.02percent NH4OAc) and 95percent CH3CN in 4 mm], Rt = 2.152 mm MS Calcd.: 265, MS Found: 210 [M-56+H].
100%
Stage #1: With triethylamine In dichloromethane at 0℃; for 0.5 h;
Stage #2: at 0℃; for 0.5 h;
A solution of N-tert-Butoxycarbonyl-(R)-(-)-3-pyrrolidinol (2.0 g, 10.7 mmol) in DCM (28 mL) was treated with TEA (2.9 mL, 21.4 mmol). The solution was cooled to 0°C for 30 minutes. Then methanesulfonyl chloride (868 iL, 1 1.2 mmol) was added. The reaction was stirred at 0°C for 30 minutes. The reaction was diluted with DCM and washed with saturated NaHCCb(aq). The organic extracts were dried over anhydrous Na2S04(S), filtered and concentrated in vacuo. The residue was purified by silica chromatography (5-95percent EtOAc in Hexanes as the gradient eluent) to afford the title compound (2.83 g, 100percent yield). MR (400 MHz, DMSO-d6) δ 5.24 (s, 1H), 3.55-3.38 (m, 3H), 3.31-3.27 (m, 1H), 3.23 (s, 3H), 2.18- 2.08 (m, 2H), 1.40 (s, 9H).
99% With triethylamine In dichloromethane at 0 - 20℃; for 6 h; Methanesulfonyl chloride (19.7 g, 172 mmol) was added to a solution of (R)-tertbutyl 3-hydroxypyrrolidine-1-carboxylate (25 g, 133 mmol) and triethylamine (20.1 g, 199 mmol) in DCM (500 mL) at 0 °C. After stirring at room temperature for 6 h, the reaction mixture was washed with 1 M HC1 (50 mL) and the aqueous layer was extracted with DCM (100 mL x 2). The combined organic layers were dried over Na2SO4 and concentrated to give (R)-tert-butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate (35 g, 99percent) as a yellow oil1H NMR (400 MHz, CDC13) (ppm): 5.28-5.23 (m, 1H), 3.70-3.40 (m, 4H), 3.04 (s, 3H), 2.34-2.07 (m, 2H), 1.46 (s, 9H).
92% With triethylamine In toluene at -30 - 20℃; Example 2. Synthesis of tert-butyl (R)-3-(methylsulfonyloxy)pyrrolidine-1-carboxylate (2); Procedure A:; To a solution of tert-butyl (R)-3-hydroxypyrrolidine-1-carboxylate (200 g, 1.07 mol) and triethylamine (167 g, 1.63 mol) in toluene (700 ml_) at -20 to -30 °C was added methanesulfonyl chloride (156 g, 1.36 mol) drop-wise while maintaining the temperature at -10 to -20 0C. The solution was warmed to ambient temperature and allowed to stir. The reaction solution was sampled hourly and analyzed by HPLC to establish completion of the reaction. Upon completion of the reaction, the suspension was filtered to remove the triethylamine hydrochloride. The filtrate was washed with ~600 mL of dilute aqueous sodium bicarbonate solution. The organic layer was dried and concentrated under reduced pressure to give 2 as a viscous oil (260 g, 92percent) which is used without further purification. 1H NMR (CDCI3, 400 MHz) δ 5.27 (m, 1 H), 3.44 - 3.76 (m, 4H), 3.05 (s, 3H), 2.26 (m, 1 H), 2.15 (m, 1 H), 1.47 (s, 9H).
92% With triethylamine In toluene at -30 - 20℃; Example 2. Synthesis of fert-butyl (R)-3-(methylsulfonyloxy)pyrrolidine-1- carboxylate (2) Procedure A: To a solution of te/t-butyl (R)-3-hydroxypyrrolidine-1- carboxylate (200 g, 1.07 mol) and triethylamine (167 g, 1.63 mol) in toluene (700 mL) at -20 to -30 °C was added methanesulfonyl chloride (156 g, 1.36 mol) drop-wise while maintaining the temperature at -10 to -20 0C. The solution was warmed to ambient temperature and allowed to stir. The reaction solution was sampled hourly and analyzed by HPLC to establish completion of the reaction. Upon completion of the reaction, the suspension was filtered to remove the triethylamine hydrochloride. The filtrate was washed with ~600 mL of dilute aqueous sodium bicarbonate solution. The organic layer was dried and concentrated under reduced pressure to give 2 as a viscous oil (260 g, 92percent) which is used without further purification. 1H NMR (CDCI3, 400 MHz) δ 5.27 (m, 1 H), 3.44 - 3.76 (m, 4H), 3.05 (s, 3H), 2.26 (m, 1 H), 2.15 (m, 1 H), 1.47 (s, 9H).
60.2% With triethylamine In dichloromethane at 0 - 20℃; Example 14. fert-Butyl (3S)-3-[4-(2-oxo-2,3-dihydro-1W-benzimidazoI-1- yl)piperidin-1-yl]pyrrolidine-1-carboxylate; Step A. The preparation of terf-butyl (3R)-3-[(methylsulfonyl)oxy]pyrrolidine-1- carboxylate <n="55"/>To (R)-N-Boc-3-pyrrolidiπol (5g, 26.7mmol) in CH2CI2 (10ml) at O0C was added Et3N (4.12g, 40.7mmol), followed by methylsulfonyl chloride (3.81g, 33.25 mmol) in 1ml of CH2CI2 slowly. The reaction mixture was warmed to RT and stirred overnight. The crude was washed with sat. NaHCO3 solution (1X ), extracted with CH2CI2 (3X ), and dried over MgSO4. After filtration and evaporation, the residue was purified by chromatography on silica gel with 30percent EtOAc/hexane to afford the mesylate tert- butyl (3R)-3-[(methylsulfonyl)oxy]pyrrolidine-1-carboxylate (4.26g, 60.2percent).
1.1 g With triethylamine In chloroform at 0 - 20℃; for 1.5 h; (R)—N—Boc-3-pyrrolidinol (935 mg) was dissolved in chloroform (15 ml), and triethylamine (1.04 ml) and methanesulfonyl chloride (467 μl) were added thereto at 0° C. After stirring at room temperature for 1.5 hours, ethyl acetate and water were added thereto to separate the organic layer. After being washed with a saturated aqueous sodium bicarbonate solution, a saturated aqueous ammonium chloride solution and water, the organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound as a colorless, oily compound (1.1 g). Physical properties: m/z[M+H]+ 266.1
1.1 g With triethylamine In chloroform at 0 - 20℃; for 1.5 h; (R)-N-Boc-3-pyrrolidinol (935 mg) was dissolved in chloroform (15 ml), and triethylamine (1.04 ml) and methanesulfonyl chloride (467 μl) were added thereto at 0° C. After stirring at room temperature for 1.5 hours, ethyl acetate and water were added thereto to separate the organic layer. After being washed with a saturated aqueous sodium bicarbonate solution, a saturated aqueous ammonium chloride solution and water, the organic layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure to obtain the title compound as a colorless, oily compound (1.1 g). Physical properties: m/z [M+H]+ 266.1

Reference: [1] Patent: WO2010/45542, 2010, A2, . Location in patent: Page/Page column 73
[2] Patent: WO2012/62783, 2012, A1, . Location in patent: Page/Page column 75
[3] Patent: WO2017/12576, 2017, A1, . Location in patent: Page/Page column 187
[4] Patent: WO2018/71454, 2018, A1, . Location in patent: Paragraph 001372; 001373; 001374
[5] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1460 - 1471
[6] Patent: WO2018/102419, 2018, A1, . Location in patent: Paragraph 0366; 0367; 0368; 0369
[7] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 13, p. 1421 - 1424
[8] Patent: WO2010/65447, 2010, A2, . Location in patent: Page/Page column 30
[9] Patent: WO2010/65443, 2010, A1, . Location in patent: Page/Page column 33
[10] Tetrahedron, 2006, vol. 62, # 24, p. 5763 - 5774
[11] Patent: WO2007/142585, 2007, A1, . Location in patent: Page/Page column 53-54
[12] Chemische Berichte, 1997, vol. 130, # 7, p. 989 - 1006
[13] Journal of Medicinal Chemistry, 1997, vol. 40, # 22, p. 3497 - 3500
[14] Journal of Antibiotics, 1998, vol. 51, # 8, p. 757 - 770
[15] Journal of Medicinal Chemistry, 1999, vol. 42, # 4, p. 677 - 690
[16] Nucleosides, Nucleotides and Nucleic Acids, 2005, vol. 24, # 5-7, p. 805 - 808
[17] Patent: US5102877, 1992, A,
[18] Patent: US5104867, 1992, A,
[19] Patent: US5124460, 1992, A,
[20] Patent: US5106853, 1992, A,
[21] Patent: WO2005/811, 2005, A1, . Location in patent: Page/Page column 61
[22] Patent: WO2009/19566, 2009, A1, . Location in patent: Page/Page column 19
[23] Journal of Medicinal Chemistry, 2008, vol. 51, # 15, p. 4601 - 4608
[24] Patent: WO2005/20975, 2005, A2, . Location in patent: Page/Page column 221
[25] Patent: WO2005/20976, 2005, A2, . Location in patent: Page/Page column 224
[26] Patent: WO2005/60949, 2005, A2, . Location in patent: Page/Page column 223
[27] Bioorganic and Medicinal Chemistry Letters, 2009, vol. 19, # 10, p. 2742 - 2746
[28] Patent: WO2010/84767, 2010, A1, . Location in patent: Page/Page column 86-87
[29] European Journal of Medicinal Chemistry, 2010, vol. 45, # 10, p. 4594 - 4600
[30] Patent: WO2007/50522, 2007, A1, . Location in patent: Page/Page column 59
[31] Patent: WO2011/79076, 2011, A1, . Location in patent: Page/Page column 97
[32] Patent: WO2011/160020, 2011, A2, . Location in patent: Page/Page column 65
[33] Patent: EP2657233, 2013, A1, . Location in patent: Paragraph 0196
[34] Patent: WO2013/138210, 2013, A1, . Location in patent: Paragraph 0199
[35] Patent: EP2803664, 2014, A1, . Location in patent: Paragraph 0136; 0138
[36] Patent: US2015/5282, 2015, A1, . Location in patent: Paragraph 0194; 0196; 0197
[37] Patent: US2016/136168, 2016, A1, . Location in patent: Paragraph 0287
[38] Patent: US2016/193210, 2016, A1, . Location in patent: Paragraph 0289
[39] Bioorganic and Medicinal Chemistry Letters, 2016, vol. 26, # 23, p. 5836 - 5841
[40] Patent: EP3239143, 2017, A2, . Location in patent: Paragraph 0547
  • 2
  • [ 124-63-0 ]
  • [ 101469-92-5 ]
  • [ 127423-61-4 ]
Reference: [1] Patent: WO2007/93363, 2007, A1, . Location in patent: Page/Page column 88
  • 3
  • [ 101385-90-4 ]
  • [ 127423-61-4 ]
Reference: [1] Journal of Medicinal Chemistry, 1999, vol. 42, # 4, p. 677 - 690
[2] Journal of Medicinal Chemistry, 1997, vol. 40, # 22, p. 3497 - 3500
  • 4
  • [ 83220-73-9 ]
  • [ 124-63-0 ]
  • [ 121-44-8 ]
  • [ 554-68-7 ]
  • [ 127423-61-4 ]
YieldReaction ConditionsOperation in experiment
100% at 3 - 14℃; A reactor was charged with ferf-butyl (R)-3-hydroxypyrrolidine-1- carboxylate (2.00 kg, 10.7 mol), toluene (8.70 kg) and triethylamine (1.75 kg, 17.3 mol). The reactor was flushed with nitrogen for 15 min. The mixture was stirred and cooled to 3 °C. Methanesulfonyl chloride (1.72 kg, mol) was slowly added (over a 2 h period) with continuous ice bath cooling (exothermic reaction) (after complete addition, the temperature was 14 °C). The mixture, now viscous with precipitated triethylamine hydrochloride, was stirred 12 h as it warmed to 20 °C. Both GC and TLC analysis (ninhydrin stain) indicated that no starting material remained. The mixture was filtered to remove the triethylamine hydrochloride, and the filtrate was returned to the reactor. The filtrate was then washed (2 x 3 kg) with 5percent aqueous sodium bicarbonate, using 15 min of stirring and 15 min of settling time for each wash. The resulting organic layer was dried over anhydrous sodium sulfate and filtered. The volatiles were removed from the filtrate under vacuum, first at 50 °C for 4 h and then at ambient temperature for 10 h. The residue weighed 3.00 kg (106percent yield) and was identical by chromatographic and NMR analysis to previously prepared samples, with the exception that it contained toluene.
Reference: [1] Patent: WO2011/112428, 2011, A2, . Location in patent: Page/Page column 28
  • 5
  • [ 24424-99-5 ]
  • [ 127423-61-4 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry (1972-1999), 1993, # 13, p. 1421 - 1424
[2] Patent: WO2011/160020, 2011, A2,
[3] Patent: EP2803664, 2014, A1,
[4] Patent: US2015/5282, 2015, A1,
  • 6
  • [ 101408-94-0 ]
  • [ 127423-61-4 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2005, vol. 24, # 5-7, p. 805 - 808
[2] Tetrahedron, 2006, vol. 62, # 24, p. 5763 - 5774
  • 7
  • [ 132945-75-6 ]
  • [ 127423-61-4 ]
Reference: [1] Nucleosides, Nucleotides and Nucleic Acids, 2005, vol. 24, # 5-7, p. 805 - 808
[2] Tetrahedron, 2006, vol. 62, # 24, p. 5763 - 5774
  • 8
  • [ 101469-92-5 ]
  • [ 127423-61-4 ]
Reference: [1] Tetrahedron, 2006, vol. 62, # 24, p. 5763 - 5774
  • 9
  • [ 127423-61-4 ]
  • [ 147081-44-5 ]
Reference: [1] Patent: US6525042, 2003, B1,
[2] Patent: EP1104754, 2001, A1,
[3] Patent: WO2011/160020, 2011, A2,
[4] Patent: US2011/178077, 2011, A1,
  • 10
  • [ 127423-61-4 ]
  • [ 199174-29-3 ]
Reference: [1] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1460 - 1471
  • 11
  • [ 127423-61-4 ]
  • [ 74-89-5 ]
  • [ 147081-59-2 ]
YieldReaction ConditionsOperation in experiment
85% at 95℃; for 60 h; Sealed tube Step 1:Mesylate 20 (1.33 g, 5 mmol) and 2 M solution of MeNH2 in THF (25 mL, 50 mmol) were loaded to a sealed tube and aged at 95 °C for 60 h, then the reaction mixture was concentrated and the residue was purified by silica gel column chromatography to give the desired amine 38 (0.85 g, 85percent).1H NMR (CDC13, 400 MHz): δ 3.58 - 3.28 (m, 3H), 3.26 - 3.02 (m, 2H), 2.43 (s, 3H), 2.08 - 1.98 (m, 1H), 1.76 - 1.63 (m, 1H), 1.45 (s, 9H).
Reference: [1] Patent: WO2011/160020, 2011, A2, . Location in patent: Page/Page column 71
  • 12
  • [ 127423-61-4 ]
  • [ 114636-37-2 ]
Reference: [1] Patent: WO2011/160020, 2011, A2,
  • 13
  • [ 127423-61-4 ]
  • [ 132945-78-9 ]
Reference: [1] Patent: US5102877, 1992, A,
  • 14
  • [ 773837-37-9 ]
  • [ 127423-61-4 ]
  • [ 132945-78-9 ]
Reference: [1] Journal of Enzyme Inhibition and Medicinal Chemistry, 2018, vol. 33, # 1, p. 1460 - 1471
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 127423-61-4 ]

Amides

Chemical Structure| 132945-75-6

[ 132945-75-6 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 141699-57-2

[ 141699-57-2 ]

tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 288314-12-5

[ 288314-12-5 ]

(3R,4R)-tert-Butyl 3,4-bis((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 148017-07-6

[ 148017-07-6 ]

(2S,4R)-tert-Butyl 2-(hydroxymethyl)-4-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.93

Chemical Structure| 129888-60-4

[ 129888-60-4 ]

tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.93

Sulfonates

Chemical Structure| 132945-75-6

[ 132945-75-6 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 141699-57-2

[ 141699-57-2 ]

tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 288314-12-5

[ 288314-12-5 ]

(3R,4R)-tert-Butyl 3,4-bis((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 148017-07-6

[ 148017-07-6 ]

(2S,4R)-tert-Butyl 2-(hydroxymethyl)-4-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.93

Chemical Structure| 129888-60-4

[ 129888-60-4 ]

tert-Butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate

Similarity: 0.93

Related Parent Nucleus of
[ 127423-61-4 ]

Pyrrolidines

Chemical Structure| 132945-75-6

[ 132945-75-6 ]

(S)-tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 141699-57-2

[ 141699-57-2 ]

tert-Butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 1.00

Chemical Structure| 288314-12-5

[ 288314-12-5 ]

(3R,4R)-tert-Butyl 3,4-bis((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.97

Chemical Structure| 148017-07-6

[ 148017-07-6 ]

(2S,4R)-tert-Butyl 2-(hydroxymethyl)-4-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate

Similarity: 0.93

Chemical Structure| 1279821-96-3

[ 1279821-96-3 ]

tert-Butyl 2,5-bis(((methylsulfonyl)oxy)methyl)pyrrolidine-1-carboxylate

Similarity: 0.88